The scientists are preparing to apply for a patent for a modified troxerutin and then proceed to preclinical trials.
Photo: GLOBAL LOOK PRESS
The Tyumen State Medical University of the Russian Ministry of Health is developing a drug for the treatment of gout and high levels of uric acid in the blood. The drug is made from a plant-based substance troxerutin, which is used to treat vein diseases. The drug will improve blood microcirculation, activate metabolism in the walls of blood vessels, work as an anti-inflammatory, which means that people with gout will no longer need to take other anti-inflammatory drugs, and this will reduce the load on the heart. and circulatory system. A recent study by scientists at the University of Auckland found that people with gout have a high risk of developing cardiovascular disease: 34% higher in women and 18% higher in men than people without the disease. Therefore, reducing the drug load on the heart is a good start for the future.
Now the scientists are preparing to apply for a patent for a modified troxerutin and then proceed to preclinical trials.
Gout (translated as “foot in a trap”) is an insidious disease, it can be confused with rheumatoid arthritis, for example. It develops from an excess of uric acid in the body. The disease begins with attacks of excruciating pain at night or in the morning, and during the day everything is fine. Other symptoms gradually increase: swollen and painful joints, especially in the legs. The skin over the affected joint turns red and becomes smooth. Then tophi are formed – nodules of white or yellow color with crumbly, “curdled” contents. The disease does not develop quickly and it is important to make a correct diagnosis in time.
